E2F2 expression induces proliferation of terminally differentiated cardiomyocytes in vivo

Cardiovascular Research

Volumn 80, Issue 2, 2008, Pages 219-226

  Ebelt, Henning ^a   Zhang, Ying ^a   Kampke, Alexander ^a   Xu, Jia ^a   Schlitt, Axel ^a   Buerke, Michael ^a   Müller Werdan, Ursula ^a   Werdan, Karl ^a   Braun, Thomas ^b  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

Author keywords

Apoptosis; Cardiomyocytes; Cell cycle; CKIs; Cyclins; E2F transcription factors

Indexed keywords

ADENOVIRUS VECTOR; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE 6; COMPLEMENTARY DNA; CYCLIN A; CYCLIN E; RNA; TRANSCRIPTION FACTOR E2F2; TRANSCRIPTION FACTOR E2F4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; HEART MUSCLE CELL; HISTOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TISSUE REGENERATION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CYCLIN A; CYCLIN E; CYCLIN-DEPENDENT KINASE INHIBITOR PROTEINS; CYCLINS; E2F2 TRANSCRIPTION FACTOR; E2F4 TRANSCRIPTION FACTOR; GENES, REPORTER; HYPERTROPHY; MICE; MICE, TRANSGENIC; MYOCYTES, CARDIAC; TRANSFECTION;

EID: 54149102852     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvn194     Document Type: Article

References (25)

1. Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, Dobert N et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 2002;106:3009-3017.
2. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004;364:141-148.
3. Assmus B, Fischer-Rasokat U, Honold J, Seeger FH, Fichtlscherer S, Tonn T et al. Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: results of the TOPCARE-CHD Registry. Circ Res 2007;100:1234-1241.
4. Kirshenbaum LA, Schneider MD. Adenovirus E1A represses cardiac gene transcription and reactivates DNA synthesis in ventricular myocytes, via alternative pocket protein- and p300-binding domains. J Biol Chem 1995;270:7791-7794.
5. Kirshenbaum LA, Abdellatif M, Chakraborty S, Schneider MD. Human E2F-1 reactivates cell cycle progression in ventricular myocytes and represses cardiac gene transcription. Dev Biol 1996;179:402-411.
6. Agah R, Kirshenbaum LA, Abdellatif M, Truong LD, Chakraborty S, Michael LH et al. Adenoviral delivery of E2F-1 directs cell cycle reentry and p53-independent apoptosis in postmitotic adult myocardium in vivo. J Clin Invest 1997;100:2722-2728.
7. von Harsdorf R, Hauck L, Mehrhof F, Wegenka U, Cardoso MC, Dietz R. E2F-1 overexpression in cardiomyocytes induces downregulation of p21CIP1 and p27KIP1 and release of active cyclin-dependent kinases in the presence of insulin-like growth factor I. Circ Res 1999;85:128-136.
8. Ebelt H, Hufnagel N, Neuhaus P, Neuhaus H, Gajawada P, Simm A et al. Divergent siblings: E2F2 and E2F4 but not E2F1 and E2F3 induce DNA synthesis in cardiomyocytes without activation of apoptosis. Circ Res 2005;96:509-517.
9. Ueno H, Perryman MB, Roberts R, Schneider MD. Differentiation of cardiac myocytes after mitogen withdrawal exhibits three sequential states of the ventricular growth response. J Cell Biol 1988;107:1911-1918.
10. Zak R. Development and proliferative capacity of cardiac muscle cells. Circ Res 1974;35(Suppl. 2):17-26.
11. Ebelt H, Braun T. Optimized, highly efficient transfer of foreign genes into newborn mouse hearts in vivo. Biochem Biophys Res Commun 2003;310:1111-1116.
12. Soonpaa MH, Field LJ. Assessment of cardiomyocyte DNA synthesis during hypertrophy in adult mice. Am J Physiol 1994;266:H1439-H1445.
13. Kass-Eisler A, Falck-Pedersen E, Alvira M, Rivera J, Buttrick PM, Wittenberg BA et al. Quantitative determination of adenovirus-mediated gene delivery to rat cardiac myocytes in vitro and in vivo. Proc Natl Acad Sci USA 1993;90:11498-11502.
14. Kass-Eisler A, Falck-Pedersen E, Elfenbein DH, Alvira M, Buttrick PM, Leinwand LA. The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer. Gene Ther 1994;1:395-402.
15. Ebelt H, Jungblut M, Zhang Y, Kubin T, Kostin S, Technau A et al. Cellular cardiomyoplasty: improvement of left ventricular function correlates with the release of cardioactive cytokines. Stem Cells 2007;25:236-244.
16. Williams ST, Smith AN, Cianci CD, Morrow JS, Brown TL. Identification of the primary caspase 3 cleavage site in alpha II-spectrin during apoptosis. Apoptosis 2003;8:353-361.
17. Engel FB, Hauck L, Boehm M, Nabel EG, Dietz R, von Harsdorf R. p21(CIP1) Controls proliferating cell nuclear antigen level in adult cardiomyocytes. Mol Cell Biol 2003;23:555-565.
18. Li Y, Jenkins CW, Nichols MA, Xiong Y. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene 1994;9:2261-2268.
19. Zhu JW, DeRyckere D, Li FX, Wan YY, DeGregori J. A role for E2F1 in the induction of ARF, p53, and apoptosis during thymic negative selection. Cell Growth Differ 1999;10:829-838.
20. Nakajima H, Nakajima HO, Tsai SC, Field LJ. Expression of mutant p193 and p53 permits cardiomyocyte cell cycle reentry after myocardial infarction in transgenic mice. Circ Res 2004;94:1606-1614.
21. Machida N, Brissie N, Sreenan C, Bishop SP. Inhibition of cardiac myocyte division in c-myc transgenic mice. J Mol Cell Cardiol 1997;29:1895-1902.
22. Soonpaa MH, Field LJ. Survey of studies examining mammalian cardiomyocyte DNA synthesis. Circ Res 1998;83:15-26.
23. Huang WY, Aramburu J, Douglas PS, Izumo S. Transgenic expression of green fluorescence protein can cause dilated cardiomyopathy. Nat Med 2000;6:482-483.
24. DeGregori J, Leone G, Ohtani K, Miron A, Nevins JR. E2F-1 accumulation bypasses a G1 arrest resulting from the inhibition of G1 cyclin-dependent kinase activity. Genes Dev 1995;9:2873-2887.
25. Radhakrishnan SK, Feliciano CS, Najmabadi F, Haegebarth A, Kandel ES, Tyner AL et al. Constitutive expression of E2F-1 leads to p21-dependent cell cycle arrest in S-phase of the cell cycle. Oncogene 2004;23:4173-4176.